Pharvaris B.V. (PHVS) 4Q22 Readouts Are Likely a Positive Catalyst - Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Justin Kim reiterated an Outperform rating and $48.00 price target on Pharvaris B.V. (NASDAQ: PHVS) ahead of two ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
